Fusion Antibodies will be attending Bio-Europe 2017
Fusion Antibodies are pleased to announce that Chris Moriarty and Hayley Close from the Fusion Team will be attending Bio-Europe 2017, being held on 6-8th November in Berlin.
Fusion Antibodies North American Business Development Agent, Dr Jody Haddow pictured alongside Dr Alan Winter.
The recently retired CEO of Genome BC, Dr Alan Winter recently received a lifetime achievement award for his services at the…
The life science sector is a key sector and jewel in the crown for the UK economy. The sector contributes a massive annual turnover of £50 Billion, comprises of over 5,000 companies and employs an estimated 175,000 people.
The life science…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-12-15 09:44:532022-04-05 10:49:22The Strategy for UK life sciences: The result So Far:
The Fusion Antibodies Team will be attending BioJapan 2016 held in Pacifico Yokohama, Japan this October.
BioJapan is Asia’s Leading Bio, Pharma R&D Event (Exhibition, Partnering, Conference) specialised in Biotechnology, Drug…
Fusion Antibodies, a UK-based contract research organisation and NB Health Laboratory (NBHL), a Japan-based biotechnology company specialising in GPCR-targeting drug discovery, are entering an alliance for a research and licence agreement in…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-10-15 10:10:392022-04-05 10:49:30Alliance between Fusion Antibodies and Nb Health Laboratory
Fusion Antibodies and BizCom Japan, a privately-held Japan-based trading and consulting company, continue to strengthen ties with Fusion’s Director Paul Kerr attending BioJapan 2016 with BizCom Japan’s Director Hiroyasu Nakatani.
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-10-15 10:07:292022-04-05 10:49:33Fusion Antibodies and Bizcom Japan continue to strengthen ties.
Fusion Antibodies has the privilege of showcasing their expertise and sponsoring the Antibody Engineering & Therapeutics conference in San Diego this December.
The Antibody Engineering & Therapeutics conference which began over…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-09-15 10:19:012022-04-05 10:49:37Fusion Antibodies sponsoring Antibody Engineering & Therapeutics conference in San Diego
Fusion Antibodies managing director Paul Kerr recently met with PharmaTV News' Adrian Dawkes to dissuss our Antibody Humanziation platform.
Fusion Antibodies managing director Paul Kerr recently met with PharmaTV News' Adrian Dawkes…
Fusion Antibodies ltd has the great honour and privilege to welcome the 20th Human Antibodies & Hybridoma conference to our home city of Belfast this November.
It continues to be a great time of hope and optimism in the knowledge…
Fusion Antibodies are happy to announce we have entered into a partnership with Swiss contract manufacturing organisation Celonic AG to collaborate on the development of high yield stable cell lines.
The deal will allow clients of Fusion…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-06-15 10:30:292022-04-05 10:49:49Fusion Antibodies announces Cell Line Development collaboration with Celonic
Fusion Antibodies are looking to hire a Business Development Manager to join their team based in Belfast, UK.
Are you looking to join an innovative manufacturer of a range of high quality antibodies for drug development and diagnostics?…
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg00Carolyn Lowry/wp-content/uploads/2022/01/fusion-antibodies-logo.svgCarolyn Lowry2016-05-15 10:35:352022-04-05 10:49:56Fusion Antibodies seek Business Development Manager
Fusion Antibodies are pleased to announce a second collaboration with Aerpio Therapeutics to apply our CDRx Antibody Humanization platform to Aerpio’s Mouse Monoclonal Antibody.
Fusion Antibodies Ltd are excited to announce our second…
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: